secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2026-06-29T20:32:03+00:00
Accession:  0001104659-26-078865
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics shareholders approve 2026 Stock Incentive Plan with 1.5M new shares
--------------------------------------------------------------------------------

- Plan adds 1,500,000 new shares; total reserve includes 2,413,730 carryover from prior plan plus returning shares.
- Shareholders approved plan with 25,872,075 for, 10,070,290 against (72% support); advisory say-on-pay also passed.
- All 12 director nominees elected; highest vote total was Kevin Tracey with 36,187,554 for, lowest was Christopher Causey with 32,342,983.
- Plan allows options, SARs, restricted stock, RSUs, stock awards, and incentive bonuses; administered by Compensation Committee.
- Effective June 26, 2026; no further grants under the 2015 plan; prior awards unaffected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465926078865/0001104659-26-078865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465926078865/tm2619258d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-078865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer